Comparative Efficacy of three Hair Oil formulations in healthy adult females

A RANDOMIZED PROSPECTIVE DOUBLE BLIND STUDY TO EVALUATE THE COMPARATIVE EFFICACY OF THREE DIFFERENT HAIR OIL FORMULATIONS H0/701, HO/702 AND HO/703 IN HEALTHY ADULT FEMALE SUBJECTS - -

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/01/007645

Enrollment

Registered

2017-01-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Dabur Vatika Enriched Coconut Hair Oil H0/701: Polyherbal Ayurvedic Hair Oil comprising herbs in coconut oil base Intervention2: Dabur Vatika Enriched Coconut Hair Oil H0/702: Polyherba

Eligibility

Inclusion criteria

Inclusion criteria: a. Female subjects aged 18 to 35 years and capable of providing written informed consent. With complaint of mild to moderate dandruff and hair fall b. Female subjects with at least shoulder length hair. c. Regular (at least twice a week) user of a commercially available brand of hair oil and shampoo. d. The female subject should be a healthy individual. e. The female subject should be considered as reliable and capable of adhering to the protocol, according to the judgment of the Investigator.

Exclusion criteria

Exclusion criteria: a. Pre-existing hair disease or scalp disease other than Hair fall (with no obvious underlying illness). b. Concomitant medications or treatments affecting the hair (e.g.: Minoxidil application, Chemotherapy) c. A positive urine pregnancy test d. Subjects not willing to provide informed consent. e. Use of styling tools,hair dyes,perms etc. f. Excessive exposure to sun,chemicals in pools (not more than once in a week), or salt in oceans . g. Pregnant, lactating or sexually active women with childbearing potential who are not using a medically accepted birth control method. h. History or presence of cardiovascular , respiratory, hepatic, renal, gastrointestinal , endocrinological , neurological disorders. i. History or presence of drug addiction. j. History of frequent and severe headache. k. Subjects who are known to have serum hepatitis, or who are carriers of the Hepatitis B surface antigen (Hbs-Ag),or Hepatitis C antibody or who are HIV positive. I. Participation in another clinical trial in less than 12 weeks before the screening visit. m.Known allergy I intolerance to the investigational product. n. Any clinical conditions that in the opinion of the Investigator would make the subject unsuitable for the trial.

Design outcomes

Primary

Measure	Time frame
Efficacy of hair oil H0/701 hair oil compared to H0/702 and H0/703 in healthy adult female subjects.Timepoint: Day 0 (baseline), 14, 28, 42, 56	—

Secondary

Measure	Time frame
overall subject safetyTimepoint: Day 0 (baseline), 14, 28, 42, 56	—

Countries

India

Contacts

Public ContactDr Arun Gupta

Dabur India Limited

arun.gupta@dabur.com01203378614

Outcome results